Literature DB >> 25914088

Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital in Madrid: Successful establishment of an OXA-48 ST11 clone.

Patricia Brañas1, Jennifer Villa1, Esther Viedma2, Jesús Mingorance3, M Angeles Orellana2, Fernando Chaves4.   

Abstract

Here we report a retrospective clinical and molecular study conducted in a tertiary care facility in southern Madrid, Spain, from January 2009 to February 2014 to investigate the epidemiology of carbapenemase-producing Klebsiella pneumoniae (CPKp). Carbapenemase genes were identified in 97 non-duplicate K. pneumoniae isolates, including 59 harbouring blaOXA-48, 37 harbouring blaVIM-1 and 1 harbouring blaKPC-2. Pulsed-field gel electrophoresis (PFGE) analysis verified the presence of 20 different clonal types, whilst multilocus sequence typing (MLST) assigned the isolates to eight sequence types (STs). A gradual increase was noted in the number of CPKp isolated, ranging from 0.8% in 2009 to 4.3% in 2013. A large outbreak was also identified, initiated in 2013 owing to a blaOXA-48 and blaCTX-M-15 co-producing ST11 clone and involving a total of 44 patients. Whole-genome sequencing was used to characterise the resistome of a representative isolate from this outbreak. Bioinformatics analysis revealed the presence of 121 genes related to antibiotic and antiseptic resistance, mutations in the ompk35 and ompk36 genes, and the presence of the blaOXA-48 gene on a 62 811bp IncL/M-type plasmid as part of a Tn1999.2 composite transposon. These results portray the increasing trend in carbapenemase-producing isolates in this hospital and highlight the successful establishment of a blaOXA-48 and blaCTX-M-15 co-producing ST11 clone that has led to the displacement of previous circulating clones.
Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Klebsiella pneumoniae; Molecular epidemiology; Multidrug-resistant; OXA-48; ST11

Mesh:

Substances:

Year:  2015        PMID: 25914088     DOI: 10.1016/j.ijantimicag.2015.02.019

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  24 in total

1.  Emergence of OXA-162 Carbapenemase- and DHA-1 AmpC Cephalosporinase-Producing Sequence Type 11 Klebsiella pneumoniae Causing Community-Onset Infection in Greece.

Authors:  Evangelia Voulgari; Aggeliki Poulou; Evangelia Dimitroulia; Lida Politi; Kyriaki Ranellou; Vassiliki Gennimata; Fani Markou; Spyros Pournaras; Athanassios Tsakris
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

2.  Molecular Characterization of OXA-48-Like-Producing Enterobacteriaceae in the Czech Republic and Evidence for Horizontal Transfer of pOXA-48-Like Plasmids.

Authors:  Anna Skalova; Katerina Chudejova; Veronika Rotova; Matej Medvecky; Vendula Studentova; Eva Chudackova; Pavel Lavicka; Tamara Bergerova; Vladislav Jakubu; Helena Zemlickova; Costas C Papagiannitsis; Jaroslav Hrabak
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  Sequence-based epidemiology of an OXA-48 plasmid during a hospital outbreak.

Authors:  Laura Hidalgo; Mark de Been; Malbert R C Rogers; Anita C Schürch; Jelle Scharringa; Anneke van der Zee; Marc J M Bonten; Ad C Fluit
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

4.  Outbreak of OXA-48-Producing Klebsiella pneumoniae Involving a Sequence Type 101 Clone in Batna University Hospital, Algeria.

Authors:  Lotfi Loucif; Ahmed Kassah-Laouar; Mahdia Saidi; Amina Messala; Widad Chelaghma; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 5.  The rapid spread of carbapenem-resistant Enterobacteriaceae.

Authors:  Robert F Potter; Alaric W D'Souza; Gautam Dantas
Journal:  Drug Resist Updat       Date:  2016-09-19       Impact factor: 18.500

6.  LN-1-255, a penicillanic acid sulfone able to inhibit the class D carbapenemase OXA-48.

Authors:  Juan A Vallejo; Marta Martínez-Guitián; Juan C Vázquez-Ucha; Concepción González-Bello; Margarita Poza; John D Buynak; Christopher R Bethel; Robert A Bonomo; German Bou; Alejandro Beceiro
Journal:  J Antimicrob Chemother       Date:  2016-04-28       Impact factor: 5.790

7.  Epidemiologic and Genotypic Review of Carbapenemase-Producing Organisms in British Columbia, Canada, between 2008 and 2014.

Authors:  Inna Sekirov; Matthew A Croxen; Corrinne Ng; Robert Azana; Yin Chang; Laura Mataseje; David Boyd; Chand Mangat; Benjamin Mack; Manal Tadros; Elizabeth Brodkin; Pamela Kibsey; Aleksandra Stefanovic; Sylvie Champagne; Michael R Mulvey; Linda M N Hoang
Journal:  J Clin Microbiol       Date:  2015-11-25       Impact factor: 5.948

8.  First Report of an OXA-48- and CTX-M-213-Producing Kluyvera Species Clone Recovered from Patients Admitted in a University Hospital in Madrid, Spain.

Authors:  Marta Hernández-García; Ricardo León-Sampedro; Blanca Pérez-Viso; María Isabel Morosini; Nieves López-Fresneña; Cristina Díaz-Agero; Teresa M Coque; Patricia Ruiz-Garbajosa; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

9.  WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain.

Authors:  Marta Hernández-García; Sergio García-Fernández; María García-Castillo; Germán Bou; Emilia Cercenado; Mercedes Delgado-Valverde; Xavier Mulet; Cristina Pitart; Jesús Rodríguez-Lozano; Nuria Tormo; Diego López-Mendoza; Jazmín Díaz-Regañón; Rafael Cantón
Journal:  JAC Antimicrob Resist       Date:  2020-10-22

10.  Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital-wide oligoclonal outbreak.

Authors:  V Pérez-Blanco; L Redondo-Bravo; G Ruíz-Carrascoso; J R Paño-Pardo; R Gómez-Gil; A Robustillo-Rodela; J García-Rodríguez; J Mingorance; R Herruzo
Journal:  Epidemiol Infect       Date:  2018-02-20       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.